Sex differences in the physiology and pharmacology of the lower urinary tract

Current Urology

Volumn 6, Issue 4, 2012, Pages 179-188

  Patra, Phani B ^a   Patra, Sayani ^a  

^a King of Prussia Business Center   (United States)

Author keywords

Lower urinary tract; Micturition; Overactive bladder; Pharmacology; Physiology; Sex difference

Indexed keywords

CARBACHOL; CONNEXIN 43; ESTROGEN; HISTAMINE; KETOPROFEN; MELOXICAM; MESSENGER RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHOSPHODIESTERASE V INHIBITOR; PROGESTERONE; TOLTERODINE; VANILLOID RECEPTOR 1;

ADRENERGIC TRANSMISSION; BLADDER; BLADDER CANCER; BLADDER CAPACITY; BLADDER CONTRACTION; BLADDER EPITHELIUM; BLADDER FUNCTION; CHOLINERGIC STIMULATION; CHOLINERGIC TRANSMISSION; ESTRUS CYCLE; GAP JUNCTION; HUMAN; MICTURITION; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEX DIFFERENCE; URETHRA; URINE INCONTINENCE;

EID: 84874079609     PISSN: 16617649     EISSN: 16617657     Source Type: Journal    
DOI: 10.1159/000343536     Document Type: Review

References (147)

1. Torgrimson BN, Minson CT: Sex and Gender: what is the difference? J Appl Physiol 2005;99:785-787.
2. Gesensway D: Reasons for sex-specific and gender-specific study of health topics. Ann Intern Med 2001;135:935-938.
3. Legato MJ: Beyond women's health the new discipline of gender-specific medicine. Med Clin North Am 2003;87:917-937.
4. Arnold AP: Promoting the understanding of sex differences to enhance equity and excellence in biomedical science. Biol Sex Differ 2010;1:1.
5. Arnold AP, van Nas A, Lusis AJ: System biology asks new questions about sex differences. Trends Endocrinol Metab 2009; 20:471-476.
6. Luczak ED, Leinwand LA: Sex-based cardiac physiology. Annu Rev Physiol 2009; 71:1-18.
7. Tan YY, Gast GC, van der Schouw YT: Gender differences in risk factors for coronary heart disease. Maturitas 2010;65:149-160.
8. Turtzo LC, McCullough LD: Sex differences in stroke. Cerebrovasc Dis 2008;26:462-474.
9. Shulman LM: Gender differences in Parkinson's disease. Gend Med 2007;4:8-18.
10. Baum LW: Sex, hormones, and Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2005;60:736-743.
11. Voskuhl R: Sex differences in autoimmune diseases. Biol Sex Differ 2011;2:1.
12. Nicot A: Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci 2009;14:4477-4515.
13. Townsend EA, Miller VM, Prakash YS: Sex differences and sex steroids in lung health and disease. Endocr Rev 2012;33:1-47.
14. Gorman JM: Gender differences in depression and response to psychotropic medication. Gend Med 2006;3:93-109.
15. Cairns BE, Gazerani P: Sex-related differences in pain. Maturitas 2009;63:292-296.
16. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A: The standarisation of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Continent Society. Neurourol Urodyn 2002;21:167-178.
17. Yamaguchi O, Honda K, Nomiya M, Shishido K, Kakizaki H, Tanaka H, Yamanishi T, Homma Y, Takeda M, Araki I, Obara K, Nishizawa O, Igawa Y, Goto M, Yokoyama O, Seki N, Takei M, Yoshida M: Defining overactive bladder as hypersensitivity. Neurourol Urodyn 2007;26(6 suppl):904-907.
18. Antunes-Lopes T, Carvalho-Barros S, Cruz CD, Cruz F, Martins-Silva C: Biomarkers in overactive bladder: A new objective and new invasive tool ? Adv Urol 2011;2011: 382431.
19. de Groat WC: A neurologic basis for the overactive bladder. Urology 1997;50(6A suppl):36-52.
20. Brading AF: A myogenic basis for the overactive bladder. Urology 1997;50 (6A suppl):57-67.
21. Yokoyama O, Mivva Y, Oyama N, Ayoki Y, Ito H, Tanase K, Ishida H, Matsuta Y, Kusukawa N, Yamauchi H, Takahara N, Watanabe N, Tsuchiyama K, Yokoi S, Akino H: Urethral sensations are related to the development of detrusor overactivity. LUTS 2011;3:59-63.
22. Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, Oh JJ, Lee SC, Jeong CK, Yoon CY, Hong SK, Byun SS, Lee SE: Prevalence and clinical features of detrusor underactivity among elderly and lower urinary tract symptoms: A comparison between men and women. Korean J Urol 2012;53:342-348.
23. Smith PP: Aging and the underactive detrusor: A failure of activity or activation? Neurourol Urodyn 2010;29:408-412.
24. Foon R, Drake MJ: The overactive bladder. Ther Adv Urol 2010;2:147-153.
25. Andersson KE: Prospective pharmacologic therapies for the overactive bladder. Ther Adv Urol 2009;1:71-83.
26. Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS: Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology 2012;80:90-96.
27. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ: Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327-336.
28. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P: Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50:1306-1314.
29. Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I: National community prevalence of overactive bladder in the United States stratified by sex and age. Urology 2011;77:1081-1087.
30. Teloken C, Caraver F, Weber FA, Teloken PE, Moraes JF, Sogari PR, Graziottin TM: Overactive bladder: prevalence and implications in Brazil. Eur Urol 2006;49:1087-1092.
31. Temml C, Heidler S, Ponholzer A, Madersbacher S: Prevalence of the overactive bladder syndrome by applying the International Continence Society definition. Eur Urol 2005;48:622-627.
32. Sekido N, Hinotsu S, Kawai K, Shimazui T, Akaza H: How many uncomplicated male and female overactive bladder patients reveal detrusor overactivity during urodynamic study? Int J Urol 2006;13:1276-1279.
33. Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K: Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int 2008;101:1381-1387.
34. Lee YS, Lee KS, Jung JH, Han DH, Oh SJ, Seo JT, Lee JG, Park HS, Choo MS: Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study. World J Urol, 2011;29:185-190.
35. Kyrklund K, Taskinen S, Rintala RJ, Pakarinen MP: Lower urinary tract symptoms from childhood to adulthood: A population based study of 594 Finnish individuals 4 to 26 years old. J Urol 2012;188:588-593.
36. Wehrberger C, Madersbacher S, Jungwirth S, Fischer P, Tragl KH: Lower urinary tract symptoms and urinary incontinence in a geriatric cohort-a population based analysis. BJU Int 2012;110:1516-1521.
37. van Dijk L, Kooij DG, Schellevis FG: Nocturia in the Dutch adult population. BJU Int 2002;90:644-648.
38. Cheung WW, Khan NH, Choi KK, Bluth MH, Vincent MT: Prevalence, evaluation and management of overactive bladder in primary care. BMC Fam Pract 2009;10:8.
39. Paick JS, Kim SW, Oh SJ, Ku JH: Voiding patterns in men and women with lower urinary tract symptoms combined with nocturia. Int J Urol 2007;14:699-703.
40. Al-Ghazo MA, Ghalayini IF, Al-Azab R, Hani OB, Matani YS, Haddad Y: Urodynamic detrusor overactivity in patients with overactive bladder symptoms. Int Neurourol J 2011;15:48-54.
41. Abarbanel J, Marcus EL: Impaired detrusor contractility in community-dwelling elderly presenting with lower urinary tract symptoms. Urology 2007;69:436-440.
42. Natsume O: Detrusor contractility and overactive bladder in patients with cerebrovascular accident. Int J Urol 2008;15:505-510.
43. Rona RJ, Li L, Chinn S: Determinants of nocturnal enuresis in England and Scotland in '90s. Dev Med Child Neurol 1997;39: 677-681.
44. Chiozza ML, Bernardinelli L, Caione P, Del Gado R, Ferrara P, Giorgi PL, Montomoli C, Rottoli A, Vertucci P: An Italian epidemiological multicenter study of nocturnal enuresis. Br J Urol 1998;81(suppl 3):86-89.
45. Bottomley G: Treating nocturnal enuresis in children in primary care. Practitioner 2011;255:23-26.
46. Schultz-Lampel D, Steuber C, Hoyer PF, Bachmann CJ, Marschall-Kehrel D, Bachmann H: Urinary incontinence in children. Dtsch Arztebl Int 2011;108:613-620.
47. Salvatore S, Serati M, Origoni M, Candiani M: Is overactive bladders in children and adults the same condition? ICI-RS 2011. Neurourol Urodyn 2012;31:349-351.
48. Kim IH, Chun H, Kwon JW: Gender differences in the effects of obesity on chronic diseases among the elderly Koreans. J Korean Med Sci 2011;26:250-257.
49. Campaigne BN, Wishner KL: Gender-specific health care in diabetes mellitus. J Gend Specif Med 2000;3:51-58.
50. Hill SR, Fayyad AM, Jones GR: Diabetes mellitus and female lower urinary tract symptoms: A review. Neurourol Urodyn 2008;27:362-367.
51. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 2003; 289:76-79.
52. Lewis CM, Schrader R, Many A, Mackay M, Rogers RG: Diabetes and urinary incontinence in 50-to 90-year-old women: A cross-sectional population-based study. Am J Obstet Gynecol 2005;193:2154-2158.
53. Lifford KL, Curhan GC, Hu FB, Barbieri RL, Grodstein F: Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Sco 2005;53:1851-1857.
54. Parsons CL: The role of the urinary epithelium in the pathogenesis of interstitial cystitis/ prostatitis/urethritis. Urology 2007;69 (Suppl 4A):9-16.
55. Powell-Boone T, Ness TJ, Cannon R, Lloyd LK, Weigent DA, Fillingim RB: Menstrual cycle affects bladder pain sensation in subjects with interstitial cystitis. J Urol 2005; 174:1832-1836.
56. Negri E, La Vecchia C: Epidemiology and prevention of bladder cancer. Eur J Cancer Prev 2001;10:7-14.
57. Horstmann M, Witthuhn R, Falk M, Stenzl A: Gender-specific differences in bladder cancer: A retrospective analysis. Gend Med 2008;5:385-394.
58. Sexton WJ, Wiegand LR, Correa JJ, Politis C, Dickinson SI, Kang LC: Bladder cancer: A review of non-muscle invasive disease. Cancer Control 2010;17:256-268.
59. Tuygun C, Kankaya D, Imamoglu A, Sertcelik A, Zengin K, Oktay M, Sertcelik N: Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: A comparative analysis of clinicopathological features and survival outcomes according to receptor expression. Urol Oncol 2011;29:43-51.
60. Longhurst PA, Levendusky M: Influence of gender and the oestrous cycle on in vitro contractile responses of the rat urinary bladder to cholinergic stimulation. Br J Pharmacol 2000;131:177-184.
61. Lee JG, Wein AJ, Levin RM: Comparative pharmacology of the male and female rabbit bladder neck and urethra: involvement of nitric oxide. Pharmacology 1994;48:250-259.
62. Fry CH, Bayliss M, Young JS, Hussain M: Influence of age and bladder dysfunction on the contractile properties of isolated human detrusor smooth muscle. BJU Int 2010;108: E91-E96.
63. Sigala S, Mirabella G, Peroni A, Pezzotti G, Simeone C, Spano P, Cunico SC: Differential gene expression of cholinergic muscarinic receptors subtypes in male and female normal human urinary bladder. Urology 2002;60:719-725.
64. Arrighi N, Bodei S, Peroni A, Mirabella G, Zani D, Simeone C, Cunico SC, Spano P, Sigala S: Detection of muscarinic receptor subtypes in human urinary bladder mucosa: age and gender-dependent modifications. Neurourol Urodyn 2008;27:421-428.
65. Sigala S, Peroni A, Mirabella G, Fornari S, Palazzolo F, Pezzotti G, Simeone C, Cunico SC, Spano P: Alpha 1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. Life Sci 2004;76: 417-427.
66. Yablonsky F, Riffaud JP, Lacolle JY, Dausse JP: Alpha 1-and alpha 2-adrenoceptors in the smooth muscle of male and female rabbit urethra. Eur J Pharmacol 1986;121:1-8.
67. Latifpour J, Kondo S, O'Hollaren B, Morita T, Weiss RM: Autonomic receptors in urinary tract: sex and age differences. J Pharmacol Exp Ther 1990;253:661-667.
68. Morita T, Latifpour J, O'Hollaren B, Wheeler MA, Weiss RM: Sex differences in function and distribution of alpha 1-and alpha 2-adrenoceptors in rabbit urethra. Am J Physiol 1987;252:F1124-1128.
69. Morita T, Masuda H, Tosaka A, Ishizaka K, Tsujii T, Kondo S: Sex differences in function and distribution of beta-adrenoceptors in rabbit urinary bladder. J Urol 1998; 159:555-558.
70. Patra PB, Westfall DP: The proportion of purinergic and cholinergic components to the overall neurotransmission to the urinary bladder differs between male and female guinea-pigs. Can J Physiol Pharmacol 1994;72(suppl 1):P13.10.1.
71. Matsui M, Motomura D, Fujikawa T, Jiang J, Takahashi S, Manabe T, Taketo MM: Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J Neurosci 2002;22:10627-10632.
72. Sugaya K, Nishijima S, Kadekawa K, Miyazato M, Mukouyama H: Relation between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactibe bladder. Biomed Res 2009;30:287-294.
73. Kories C, Czyborra C, Fetscher C, Schneider T, Krege S, Michel MC: Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder: differential regulation of M2 and M3 receptors? Naunyn Schmiedebergs Arch Pharmacol 2003;367:524-531.
74. Creed KE, Loxley RA, Phillips JK: Functional expression of muscarinic and purinoceptors in the urinary bladder of male and female rats and guinea pigs. J Smooth Muscle Res 2010;46:201-215.
75. Kullmann FA, Artim DE, Birder LA, de Groat WC: Activation of muscarinic receptors in rat bladder sensory pathways alters reflex bladder activity. J Neurosci 2008;28: 1977-1987.
76. Liang W, Leung PC: Variations in carbachol-and ATP-induced contractions of the rat detrusor: effects of gender, mucosa and contractile direction. Int Urol Nephrol 2012;44:1641-1648.
77. Yoshida M, Masunaga K, Satoji Y, Maeda Y, Nagata T, Inadome A: Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in urothelium and its clinical significance. J Pharmacol Sci 2008;106:193-198.
78. Kobayashi H, Yoshiyama M, Zakoji H, Takeda M, Araki I: Sex differences in the expression profile of acid-sensing ion channels in the mouse urinary bladder: A possible involvement in irritative bladder symptoms. BJU Int 2009;104:1746-1751.
79. Ponglowhapan S, Church DB, Khalid M: Differences in the proportion of collagen and muscle in the canine lower urinary tract with regard to gonadal status and gender. Theriogenology 2008;70:1516-1524.
80. Ponglowhapan S, Church DB, Khalid M: Expression of cyclooxygenase-2 in the canine lower urinary tract with regard to the effects of gonadal status and gender. Theriogenology 2009;71:1276-1288.
81. Zvara P, Kliment J Jr, DeRoss AL, Irwin BH, Malley SE, Plante MK, Vizzard MA: Differential expression of bladder neurotrophic factor mRNA in male and female rats after bladder outflow obstruction. J Urol 2002;168:2682-2688.
82. Mattern HM, Lloyd PG, Sturek M, Hardin CD: Gender and genetic differences in bladder smooth muscle PPAR mRNA in a porcine model of the metabolic syndrome. Mol Cell Biochem 2007;302:43-49.
83. Vignozzi L, Filippi S, Morelli A, Comeglio P, Cellai I, Sarchielli E, Maneschi E, Mancina R, Gacci M, Vannelli GB, Maggi M: Testosterone/estradiol ratio regulates NOinduced bladder relaxation and responsiveness to PDE5 inhibitors. J Sex Med 2012; 9:3028-3040.
84. Pontari MA, Ruggieri MR: Sex differences and role of nitric oxide in blood flow of canine urinary bladder. Am J Physiol 1999; 276:R407-413.
85. Valeri A, Ceccarelli I, Fiorenzani P, Aloisi AM, Sgaragli G, Pessina F: Effects of 17beta-estradiol on rat urinary bladder: gender differences in anoxia-glucopenia and reperfusion damage. Neurourol Urodyn 2009;28:535-541.
86. Pessina F, Valeri A, Dragoni S, Valoti M, Sgaragli G: Gender related neuronal and smooth muscle damage of guinea pig isolated urinary bladder from anoxia-glucopenia and reperfusion injury and its relationship to glycogen content. Neurourol Urodyn 2007;26:416-423.
87. Tyagi P, Tyagi V, Yoshimura N, Witteemer E, Barclay D, Loughran PA, Zamora R, Vodovotz Y: Gender-based reciprocal expression of transforming growth factor-b1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis. J Inflamm 2009;6:23.
88. Savolainen S, Santti R, Streng T, Gustafsson JA, Harkonen P, Makela S: Sex specific expression of progesterone receptor in mouse lower urinary tract. Mol Cell Endocrinol 2005;230:17-21.
89. Song SH, Joo HT, Cho HW, Hwang HW, Lee KH, Kim DK: Sex-and age-related changes in connexin 43 expression in normal rat bladder. Int Neurourol J 2011; 15:25-28.
90. Groutz A, Blaivas JG, Pies C, Sassone AM: Learned voiding dysfunction (non-neurogenic, neurogenic bladder) among adults. Neurourol Urodyn 2001;20:259-268.
91. Maggi CA, Giuliani S, Santicioli P, Meli A: Analysis of factors involved in determining urinary bladder voiding cycle in urethaneanesthetized rats. Am J Physiol 1986;251: R250-257.
92. Streng T, Santti R, Talo A: Similarities and differences in female and male rat voiding. Neurourol Urodyn 2002;21:136-141.
93. Cruz Y, Downie JW: Sexually dimorphic micturition in rats: relationship of perineal muscle activity to voiding pattern. Am J Physiol Regul Integr Comp Physiol 2005; 289:R1307-1318.
94. Schmidt F, Yoshimura Y, Ni RX, Kneesel S, Constantinou CE : Influence of gender on the diurnal variation of urine production and micturition characteristics of the rat. Neurourol Urodyn 2001;20:287-295.
95. Patra PB, Jugus MJ, Laping NJ: Sex difference in cystometry of normal and hypertensive conscious rat. Curr Urol 2007;1:84-88.
96. Powell AJ, Wolff PR: Sex differences in mouse urination patterns. Animal Behav 1982;30:1207-1211.
97. Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, Takahashi S, Taketo MM: Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA 2000;97:9579-9584.
98. Aboushwareb T, Zhou G, Deng FM, Turner C, Andersson KE, Tar M, Zhao W, Melman A, D'Agostino R Jr, Sun TT, Christ GJ: Alterations in bladder function associated with urothelial defects in uroplakin II and IIIa knockout mice. Neurourol Urodyn 2009;28:1028-1033.
99. Cornelissen LL, Brooks DP, Wibberley A: Female, but not male, serotonin reuptake transporter (5-HTT) knockout mice exhibit bladder instability. Auton Neurosci 2005; 122:107-110.
100. Cornelissen LL, Misajet B, Brooks DP, Hicks A: Influence of genetic background and gender on bladder function in the mouse. Auton Neurosci 2008;140:53-58.
101. Yoshiyama M, Kobayashi H, Araki I, Du S, Zakoji H, Takeda M: Sex-related differences in activity of lower urinary tract in response to intravesical acid irritation in decerebrate unanesthetized mice. Am J Physiol Regul Integr Comp Physiol 2008;295: R954-960.
102. Yoshiyama M, Araki I, Kobayashi H, Zakoji H, Takeda M: Functional roles of TRPV1 channels in lower urinary tract irritated by acetic acid: in-vivo evaluations on the sex difference in decerebrate unanesthetized mice. Am J Physiol Renal Physiol 2010; 298:F1351-1359.
103. Yoshimura Y, Schmidt F, Constantinou CE: Gender specificity of tolterodine on micturition and the diurnal variation of urine production of the conscious rat. BJU Int 2000;86:879-885.
104. Levin RM, Juan YS, Whitback C, Perez-Martinez FC, Lin WY: The effect of darifenacin on overactive bladders in female and male rabbits. Int Urol Nephrol 2008;40: 303-309.
105. Maeda H, Fujita K, Kobayashi H, Ushiki J, Nakanishi T, Tamai I: Novel LC-MS/MS method for simultaneous uantification of KW-7158, a new drug candidate for urinary incontinence and bladder hyperactivity and its metabolite in rat plasma: A pharmacokinetic study in male and female rats. Arzneimittelforschung 2012;62:213-221.
106. Patra PB: Micturition in normal and hypertensive conscious rat: sex difference in cyclooxygenase inhibition. Curr Urol 2007;1: 134-140.
107. Michel MC, Schneider T, Krege S, Goepel M: Does gender or age affect the efficacy and safety of tolterodine? J Urol 2002;168: 1027-1031.
108. Frazier EP, Schneider T, Michel MC: Effects of gender, age and hypertension on beta-adrenergic receptor function in rat urinary bladder. Naunyn Schmiedebergs Arch Pharmacol 2006;373:300-309.
109. Schneider T, Fetscher C, Michel MC: Human Urinary bladder strip relaxation by the beta-adrenoceptor agonist isoprenaline: methodological considerations and effects of gender and age. Front Pharmacol 2011;2: 1-8.
110. Malone-Lee J, Wahedna I: Characterisation of detrusor contractile function in relation to old age. Br J Urol 1993;72:873-880.
111. Nuotio M, Jylhä M, Luukkaala T, Tammela TL: Urgency, urge incontinence and voiding symptoms in men and women aged 70 years and over. BJU Int 2002;89:350-355.
112. Gulur DM, Drake MJ: Management of overactive bladder. Nat Rev Urol 2010;7:572-582.
113. Yamaguchi K, Kobayashi M, Kato T, Akita K: Origins and distribution of nerves to the female urinary bladder: New anatomical findings in the sex differences. Clin Anat 2011;24:880-885.
114. Van der Werf BA, Creed KE: Mechanical properties and innervation of the smooth muscle layers of the urethra of greyhounds. BJU Int 2002;90:588-595.
115. Kontani H, Shiraoya C: Sex differences in urethral pressure response to electrical stimulation of the hypogastric nerves in rats. J Urol 2000;163:1364-1368.
116. Cahill L: Why sex matters for neuroscience. Nat Rev Neurosci 2006;7:477-484.
117. Cosgrove KP, Mazure CM, Staley JK: Evolving knowledge of sex differences in brain structure, function, and chemistry. Bio Psychiatry 2007;62:847-855.
118. Tobet S, Knoll JG, Hartshorn C, Aurand E, Stratton M, Kumar P, Searcy B, McClellan K: Brain sex differences and hormone influences: A moving experience? J Neuroendocrinol 2009;21:387-392.
119. Lenz KM, Nugent BM, McCarthy MM: Sexual differentiation of the rodent brain: dogma and beyond. Front Neurosci 2012; 6:26.
120. Seseke S, Baudewig J, Kallenberg K, Ringert RH, Seseke F, Dechent P: Gender differences in voluntary micturition control: an fMRI study. Neuroimage 2008;43:183-191.
121. Kuhtz-Buschbeck JP, Gilster R, van der Horst C, Hamann M, Wolff S, Jansen O: Control of bladder sensations: an fMRI study of brain activity and effective connectivity. Neuroimage 2009;47:18-27.
122. Rechberger T, Skorupski P: The controversies regarding the role of estrogens in urogynecology. Folia Histochem Cytobiol 2007;45(Supp 1):17-21.
123. Liu CC, Kuo TB, Yang CC: Effects of estrogen on gender-related autonomic differences in humans. Am J Physiol Heart Circ Physiol 2003;285:H2188-2193.
124. Celayir S: Is there a "bladder sex"? The relation of different sex hormones and sex hormone receptors in bladder in childhood. Med Hypotheses 2002;59:186-190.
125. Yu Y, Shen Z, Zhou X, Chen S: Effects of steroid hormones on morphology and vascular endothelial growth factor expression in female bladder. Urology 2009;73:1210-1217.
126. Patra PB, Thorneloe KS, Laping NJ: Effect of estrogen and progesterone on urodynamics in conscious rat. Urology 2009;74:463-466.
127. Tek M, Balli E, Cimen B, Efesoy O, Oguz I, Cayan S: The effect of testosterone replacement therapy on bladder functions and histology in orchiectomized mature male rats. Urology 2010;75:886-890.
128. Keast JR, Saunders RJ: Testosterone has potent, selective effects on the morphology of pelvic autonomic neurons which control the bladder, lower bowel and internal reproductive organs of the male rat. Neuroscience 1998;85:543-556.
129. Chavalmane AK, Comeglio P, Morelli A, Filippi S, Fibbi B, Vignozzi L, Sarchielli E, Marchetta M, Failli P, Sandner P, Saad F, Gacci M, Vannelli GB, Maggi M: Sex steroid receptors in male human bladder: expression and biological function. J Sex Med 2010;7:2698-2713.
130. Knight GE, Burnstock G: The effect of pregnancy and the oestrus cycle on purinergic and cholinergic responses of the rat urinary bladder. Neuropharmacology 2004; 46:1049-1056.
131. Franconi F, Brunelleschi S, Steardo L, Cuomo V: Gender differences in drug response. Pharmacol Res 2007;55:81-95.
132. Soldin OP, Chung SH, Mattison DR: Sex differences in drug disposition. J Biomed Biotechnol 2011;2011:187103.
133. Schwartz JB: The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmachol Ther 2007;82:87-96.
134. Nicolson TJ, Mellor HR, Roberts RR: Gender differences in drug toxicity. Trends Pharmacol Sci 2010;31:108-114.
135. Seeman MV: Mechanisms of sex difference: A historical perspective. J Womens Health 2009;18:861-866.
136. Gillies GE, McArthur S: Estrogen actions in the brain and the basis for differential action in men and women: A case for sexspecific medicines. Pharmacol Rev 2010; 62:155-198.
137. Juul KV, Klein BM, Sandstrom R, Erichsen L, Norgaard JP: Gender difference in antidiuretic response to desmopressin. Am J Physiol Renal Physiol 2011;300:F1116-F1122.
138. Hong GS, Shim BS, Chung WS, Yoon H: Correlation between metabolic syndrome and lower urinary tract symptoms of males and females in the aspect of gender-specific medicine: A single institutional study. Korean J Urol 2010;51:631-635.
139. Pinn VW: Sex and Gender factors in medical studies: implications for health and clinical practice. JAMA 2003;289:397-400.
140. Minaglia S, Ozel B, Bizhang R, Mishell DR Jr: Increased prevalence of interstitial cystitis in women with detrusor overactivity refractory to anticholinergic therapy. Urology 2005;66:702-706.
141. Palea S, Artibani W, Ostardo E, Trist DG, Pietra C: Evidence for purinergic neurotransmission in human bladder affected by interstitial cystitis. J Urol 1993;150:2007-2012.
142. Sun Y, Chai TC: Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis. Am J Physiol Cell Physiol 2006;290:C27-34.
143. Patra PB, Westfall DP: Potentiation of purinergic neurotransmission in guinea pig urinary bladder by histamine. J Urol 1994;151: 787-790.
144. Patra PB, Westfall DP: Potentiation by bradykinin and substance P of purinergic neurotransmission in urinary bladder. J Urol 1996;156:532-535.
145. Burnstock G: Therapeutic potential of purinergic signalling for diseases of the urinary tract. BJU Int 2011;107:192-204.
146. Vesela R, Aronsson P, Andersson M, Wsol V, Tobin G: The potential of non-adrenergic, non-cholinergic targets in the treatment of interstitial cystitis/painful bladder syndrome. J Physiol Pharmacol 2012;63:209-216.
147. Dielissen PW, Bottema BJ, Verdonk P, Lagro-Janssen TL: Incorporating and evaluating an integrated gender-specific medicine curriculum: A survey study in Dutch GP training. BMC Med Educ 2009;9:58.